Spotlight on Hodgkin Lymphoma
We invite you to learn more about:
- Treatment advances for Hodgkin lymphoma
- Side-effect management
- Treatment options for relapsed/refractory patients
- Monitoring for long term and late effects
- The importance of discussing quality of life issues with your healthcare team
Jeremy Abramson, MD
Director, Jon and Jo Ann Hagler Center for Lymphoma
Massachusetts General Hospital Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Program Support
Support for this program is provided by The Leukemia & Lymphoma Society.